Skip to main content
logo
Aarti Drugs Limited (NSE:AARTIDRUGS)
India flag India · Delayed Price · Currency is INR
352.70
+6.30 (1.82%)
Apr 2, 2026, 3:29 PM IST

Aarti Drugs Revenue

Aarti Drugs had revenue of 6.02B INR in the quarter ending December 31, 2025, with 8.10% growth. This brings the company's revenue in the last twelve months to 25.22B, up 8.22% year-over-year. In the fiscal year ending March 31, 2025, Aarti Drugs had annual revenue of 23.87B, down -5.60%.

Revenue (ttm)
25.22B
Revenue Growth
+8.22%
P/S Ratio
1.27
Revenue / Employee
19.64M
Employees
1,284
Market Cap
32.13B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202523.87B-1.42B-5.60%
Mar 31, 202425.29B-1.87B-6.90%
Mar 31, 202327.16B2.27B9.14%
Mar 31, 202224.89B3.34B15.49%
Mar 31, 202121.55B3.49B19.31%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Akums Drugs and Pharmaceuticals42.60B
Aarti Pharmalabs18.01B
Indoco Remedies17.60B
Innova Captab14.97B
Solara Active Pharma Sciences12.55B
Windlas Biotech8.68B
Orchid Pharma8.11B
RPG Life Sciences6.74B
Revenue Rankings

Aarti Drugs News

More News